TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23041804

Group type: EXPERIMENTAL
Intervention: CEC curtains
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard curtains
Number of subjects: 30
Study: 18947437

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (0-2 g/d) for up to 10 weeks
Number of subjects: 0
Study: 17725415

Group type: EXPERIMENTAL
Intervention: Emtricitabine (FTC) once daily (QD)
Number of subjects: 546

Group type: COMPARATOR
Intervention: Stavudine (d4T) twice daily
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Presence of K103N mutation
Number of subjects: 546
Study: 15686273

Group type: EXPERIMENTAL
Intervention: Routine hospital procedure of compressed air exposure to 240 kPa for approximately 115 min with 12 min of terminal oxygen breathing.
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Revised profile with 12 and 24 min of terminal oxygen breathing and a Nitrox profile (40.5% O2 in Nitrogen during 90 min of isobaric phase).
Number of subjects: 9
Study: 11728950

Group type: EXPERIMENTAL
Intervention: Prednisolone (0.8 mg/kg/d) for 1 month
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 9226337

Group type: EXPERIMENTAL
Intervention: 50 mg naltrexone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8435260

Group type: EXPERIMENTAL
Intervention: Propofol 2.5 mg kg‐1 and alfentanil 10 micrograms kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol 2.5 mg kg‐1, alfentanil 10 micrograms kg‐1, and lignocaine 1 mg kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol 2.5 mg kg‐1 and alfentanil 20 micrograms kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol 2.5 mg kg‐1, alfentanil 20 micrograms kg‐1, and lignocaine 1 mg kg‐1
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lignocaine group (with lignocaine)
Number of subjects: 60
Study: 3679064

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29160731

Group type: EXPERIMENTAL
Intervention: cART with EPOCH
Number of subjects: 0

Group type: COMPARATOR
Intervention: non-cART
Number of subjects: 0
Study: 28393774

Group type: EXPERIMENTAL
Intervention: Rajyoga meditation
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (patient counseling)
Number of subjects: 150
Study: 26247196

Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 g/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 0
Study: 24011104

Group type: EXPERIMENTAL
Intervention: Emotional Intelligence (EI) training group
Number of subjects: 590

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 590
Study: 21182491

Group type: EXPERIMENTAL
Intervention: Buprenorphine (20 µg·h(‐1), 144 h)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Fentanyl (25 µg·h(‐1), 72 h)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Buprenorphine and Fentanyl
Number of subjects: 22
Study: 18311330

Group type: EXPERIMENTAL
Intervention: Heme iron supplemented filling in low iron feed
Number of subjects: 2

Group type: COMPARATOR
Intervention: Normal feed with ferrous sulphate
Number of subjects: 2
Study: 17165496

Group type: EXPERIMENTAL
Intervention: Frequency-changeable electroacupuncture at Qimen (LR 14), Liangmen (ST 21), Riyue (GB 24), Danshu (BL 19), Ganshu (BL 18), Yanglingquan (GB 34), and Dannang (EX-LE6)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Chinese medicine Paishi Decoction, 40 mL of 33% magnesium sulfate, 30 mL of 0.5% hydrochloric acid, fat diet, and Tuian Yunjing Instrument
Number of subjects: 120
Study: 14556128

Group type: EXPERIMENTAL
Intervention: levobupivacaine 0.5%
Number of subjects: 62

Group type: COMPARATOR
Intervention: bupivacaine 0.5%
Number of subjects: 62
Study: 10765962

Group type: EXPERIMENTAL
Intervention: DMPS (2 mg/kg body weight) injected intravenously
Number of subjects: 80
Study: 9050975

Group type: EXPERIMENTAL
Intervention: Sustained-release verapamil/trandolapril
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Atenolol/chlorthalidone
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Lisinopril/hydrochlorothiazide
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study: 8288503

Group type: EXPERIMENTAL
Intervention: Ceftazidime 1 g tds
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ceftazidime 2 g tds
Number of subjects: 50
Study: 3506198

Group type: EXPERIMENTAL
Intervention: Village health workers (VHWs) trained mothers in experimental villages
Number of subjects: 647

Group type: COMPARATOR
Intervention: Control villages (no training)
Number of subjects: 647

Group type: EXPERIMENTAL
Intervention: Solutions made in experimental villages
Number of subjects: 647

Group type: COMPARATOR
Intervention: Solutions made in control villages
Number of subjects: 647
Study: 29050992

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 84496

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84496
Study: 27315583

Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Fulvestrant (500 mg)
Number of subjects: 116
Study: 25902591

Group type: EXPERIMENTAL
Intervention: Heifer community development activities
Number of subjects: 607

Group type: COMPARATOR
Intervention: Control group (no Heifer activities for the first year)
Number of subjects: 607
Study: 22840293

Group type: EXPERIMENTAL
Intervention: Bioenterics intragastric balloon (BIB)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham BIB placement
Number of subjects: 18
Study: 20155359

Group type: EXPERIMENTAL
Intervention: Ankaferd Blood Stopper (ABS)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Ankaferd Blood Stopper (ABS) for crossover patients
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Ankaferd Blood Stopper (ABS) for bleeding intensity 1 and 2 patients
Number of subjects: 49
Study: 18187087

Group type: EXPERIMENTAL
Intervention: Supervised treadmill exercise (Trained; n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard medical care (Control; n = 10)
Number of subjects: 20
Study: 15678632

Group type: EXPERIMENTAL
Intervention: Public perception of alcohol use by physicians on duty
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Public beliefs about alcohol use by physicians on duty
Number of subjects: 408
Study: 11691702

Group type: EXPERIMENTAL
Intervention: Early detection strategies (1997-1998)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual detection methods (1993-1994)
Number of subjects: 0
Study: 9586668

Group type: EXPERIMENTAL
Intervention: Clodronate (1600 mg/day orally)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 8031562

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 30
Study: 2686433

Group type: EXPERIMENTAL
Intervention: Intravenous diphenylhydantoin (1,000 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 4926948

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Melphalan
Number of subjects: 274

Group type: COMPARATOR
Intervention: Control (Blood Urea Concentration < 40 mg/100 ml)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Control (Blood Urea Concentration 40-79 mg/100 ml)
Number of subjects: 274

Group type: COMPARATOR
Intervention: Control (Blood Urea Concentration ≥ 80 mg/100 ml)
Number of subjects: 274
Study: 7352850

Group type: EXPERIMENTAL
Intervention: Methadone hydrochloride (60 mg daily)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Methadone hydrochloride (increased doses)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Methadyl acetate
Number of subjects: 68
Study: 30194663

Group type: EXPERIMENTAL
Intervention: Low-dose daily prednisolone (0.2-0.3 mg/kg daily)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard alternate-day prednisolone (0.5-0.7 mg/kg alternate day)
Number of subjects: 61
Study: 28444800

Group type: EXPERIMENTAL
Intervention: Endoscopic meatus scoring scale (meatuscopy)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Sniff test
Number of subjects: 310
Study: 25400127

Group type: EXPERIMENTAL
Intervention: Educational programme with telephone follow-up (N = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (N = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups (Educational programme and Control)
Number of subjects: 60
Study: 24163121

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (no RIPC)
Number of subjects: 200
Study: 21777100

Group type: EXPERIMENTAL
Intervention: Group D (n=15, dentin group)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Group E3 (n=15, with cuspal coverage and cervical enamel)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Group E1 and E2 (n=15 each, with cervical enamel)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (n=5, intact teeth without preparation or restoration)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Group D
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Groups E1, E2, and E3
Number of subjects: 65
Study: 19162226

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Amobarbital
Number of subjects: 40
Study: 17322141

Group type: EXPERIMENTAL
Intervention: Telmisartan (80 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Nisoldipine (10 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Telmisartan (80 mg) with nisoldipine (10 mg)
Number of subjects: 37
Study: 15083369

Group type: COMPARATOR
Intervention: ACE I/D genotype
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Strength training program
Number of subjects: 57
Study: 11684988

Group type: EXPERIMENTAL
Intervention: Pressure-controlled inverse ratio ventilation (PC-IRV) 2:1
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Pressure-controlled inverse ratio ventilation (PC-IRV) 4:1
Number of subjects: 17

Group type: COMPARATOR
Intervention: Pressure-controlled ventilation (PCV) 1:2
Number of subjects: 17
Study: 9579838

Group type: EXPERIMENTAL
Intervention: IL-2/IFN-alpha and tamoxifen
Number of subjects: 128

Group type: COMPARATOR
Intervention: Tamoxifen only
Number of subjects: 128
Study: 8279942

Group type: EXPERIMENTAL
Intervention: 0.01 mg/kg per hour of recombinant human IGF-I
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 11
Study: 3183852

Group type: EXPERIMENTAL
Intervention: Heparin and dipyridamole
Number of subjects: 58

Group type: COMPARATOR
Intervention: Supportive management only
Number of subjects: 58
Study: 31619121

Group type: EXPERIMENTAL
Intervention: Multilingual listeners (n=29)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Monolingual listeners (n=19)
Number of subjects: 48
Study: 29017282

Group type: EXPERIMENTAL
Intervention: Interleukin 6 (IL6)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: IP10
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Monokine induced by IFN-γ (MIG)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Interferon β (IFNβ)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: IL6, IL1β, IL1Rα (multivariate analysis)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: IFNβ (multivariate analysis)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Longitudinal analysis of TB-associated markers (IL6, IP10, sCD14, IFNγ)
Number of subjects: 186
Study: 27122214

Group type: EXPERIMENTAL
Intervention: 200 U Botulinum‐A toxin injection
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 300 U Botulin‐A toxin injection
Number of subjects: 60

Group type: COMPARATOR
Intervention: 200 U Botulin‐A toxin injection
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both doses of Botulinum‐A toxin
Number of subjects: 60
Study: 23337181

Group type: EXPERIMENTAL
Intervention: Dissonance-based thin-ideal internalization reduction program
Number of subjects: 977

Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 977
Study: 21485709

Group type: COMPARATOR
Intervention: Reference formulation (Xobix)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Test formulation (Melfax)
Number of subjects: 18
Study: 19690253

Group type: EXPERIMENTAL
Intervention: GlideScope Ranger
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: V‐MAC Storz Berci DCI
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: McGrath
Number of subjects: 450
Study: 16983600

Group type: EXPERIMENTAL
Intervention: R‐(‐)‐linalool
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: S‐(+)‐linalool
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both linalool enantiomers
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 24
Study: 15195759

Group type: EXPERIMENTAL
Intervention: Cirrhotic patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cirrhotic patients with minimal HE
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 20
Study: 11265020

Group type: EXPERIMENTAL
Intervention: Computerized protocol for ventilatory support
Number of subjects: 67

Group type: COMPARATOR
Intervention: Nonprotocol (physician-directed ventilatory support)
Number of subjects: 67
Study: 9492717

Group type: EXPERIMENTAL
Intervention: Extraamniotic saline infusion
Number of subjects: 85

Group type: COMPARATOR
Intervention: Intracervical application of dinoprost 0.5 mg (prostaglandin)
Number of subjects: 85
Study: 8045656

Group type: EXPERIMENTAL
Intervention: Allopurinol (600 mg before operation)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (no allopurinol)
Number of subjects: 18
Study: 2692571

Group type: EXPERIMENTAL
Intervention: Maxepa (20 capsules/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 21
Study: 4908341

Group type: EXPERIMENTAL
Intervention: Amantadine hydrochloride (100 mg, twice daily for 10 days)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 30816982

Group type: EXPERIMENTAL
Intervention: Multidimensional Support Program (MSP)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 98
Study: 28710219

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 316

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 316
Study: 25306925

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (n = 33)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard care (n = 35)
Number of subjects: 68
Study: 23685830

Group type: EXPERIMENTAL
Intervention: Fibrin spray (10 mL)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Bipolar sealer (radiofrequency energy)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard electrocautery (control)
Number of subjects: 95
Study: 21864624

Group type: EXPERIMENTAL
Intervention: Matrix M™ adjuvanted virosomal H5N1 vaccine (1.5, 7.5, or 30 μg HA with 50 μg Matrix M™)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Virosomal H5N1 vaccine alone (30 μg HA)
Number of subjects: 60
Study: 19704393

Group type: COMPARATOR
Intervention: Male partners of teen girls (15-19 years)
Number of subjects: 514
Study: 17670909

Group type: COMPARATOR
Intervention: Postnatal support
Number of subjects: 450

Group type: COMPARATOR
Intervention: Antenatal education
Number of subjects: 450
Study: 15020026

Group type: EXPERIMENTAL
Intervention: Smoking cessation or reduction programme
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Both smoking cessation and breast‐feeding education and support programmes
Number of subjects: 297

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 297
Study: 11331165

Group type: EXPERIMENTAL
Intervention: 10 micro g/kg neostigmine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 5 micro g/kg neostigmine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 45
Study: 9060525

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiation at weeks 1 to 4 (Group I)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Delayed chemoradiation at weeks 6 to 9 (Group II)
Number of subjects: 103
Study: 8359923

Group type: EXPERIMENTAL
Intervention: CVD 103-HgR live oral cholera vaccine (5 x 10^9 CFU)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: CVD 103-HgR live oral cholera vaccine (5 x 10^8 CFU)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study: 3772096

Group type: EXPERIMENTAL
Intervention: Regular alcohol consumption (0.8 g/kg per day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Alcohol-free control period
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Regular alcohol consumption
Number of subjects: 10
Study: 31854112

Group type: EXPERIMENTAL
Intervention: One-month dual anti-platelet therapy (DAPT) with ticagrelor and aspirin followed by 23-month ticagrelor monotherapy
Number of subjects: 6693

Group type: COMPARATOR
Intervention: Standard 12-month DAPT followed by 12-month aspirin monotherapy
Number of subjects: 6693

Group type: EXPERIMENTAL
Intervention: Experimental treatment (ticagrelor monotherapy after DAPT)
Number of subjects: 6693

Group type: COMPARATOR
Intervention: Control treatment (standard DAPT followed by aspirin)
Number of subjects: 6693
Study: 29642062

Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant
Number of subjects: 71
Study: 27130717

Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT) applied by a physiotherapist on postoperative day 1
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Kinesiology taping (KT)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo control (usual dressing tape)
Number of subjects: 92
Study: 24819579

Group type: EXPERIMENTAL
Intervention: Peer-led intervention (5-month program facilitated by high school mentors)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control arm (standard curriculum)
Number of subjects: 151
Study: 23106929

Group type: EXPERIMENTAL
Intervention: Anxiety symptoms
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Depression symptoms
Number of subjects: 175

Group type: COMPARATOR
Intervention: Neither anxiety nor depression symptoms
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Concomitant psychotropic medication use
Number of subjects: 175
Study: 20192867

Group type: EXPERIMENTAL
Intervention: Platform switching
Number of subjects: 18

Group type: COMPARATOR
Intervention: Traditional approach
Number of subjects: 18
Study: 18400948

Group type: EXPERIMENTAL
Intervention: Irradiated single-strand tendons in the old age group
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Nonirradiated double-strand tendons in the old age group
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Single-strand irradiated old tendons
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Irradiated young tendons and old double-strand tendons
Number of subjects: 126

Group type: COMPARATOR
Intervention: Nonirradiated tendons
Number of subjects: 126
Study: 16095144

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate-salmeterol (100/50 microg) twice daily for 12 weeks
Number of subjects: 203

Group type: COMPARATOR
Intervention: Fluticasone propionate (100 microg) alone twice daily for 12 weeks
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate-salmeterol (100/50 microg) and Fluticasone propionate (100 microg)
Number of subjects: 203
Study: 12498545

Group type: EXPERIMENTAL
Intervention: Neutral condition (22 degrees C)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hot condition (35 degrees C)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cold condition (5 degrees C)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cortisol concentration and perceived exertion
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Body temperatures
Number of subjects: 12
Study: 10490110

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) and UV-A combination treatment
Number of subjects: 135

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) alone
Number of subjects: 135

Group type: COMPARATOR
Intervention: UV-A alone
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Combination of FP and UV-A
Number of subjects: 135
Study: 7472588

Group type: EXPERIMENTAL
Intervention: Patient Support Device (PSD)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control (no PSD)
Number of subjects: 190
Study: 1638252

Group type: EXPERIMENTAL
Intervention: Current smokers (≥20 cigarettes/day)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Current smokers (<20 cigarettes/day)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Women with more than one sexual partner
Number of subjects: 228

Group type: COMPARATOR
Intervention: Women with only one sexual partner
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Use of oral contraceptives
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Lower risk groups
Number of subjects: 228
Study: 6736276

Group type: EXPERIMENTAL
Intervention: Thiothixene
Number of subjects: 19
Study: 31409300

Group type: EXPERIMENTAL
Intervention: Enhanced preoperative education about continuous femoral nerve block with patient-controlled analgesia (PCA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (standard education)
Number of subjects: 60
Study: 30486843

Group type: EXPERIMENTAL
Intervention: Behavioral Activation (BA) plus Usual Care (UC)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 90
Study: 26951772

Group type: EXPERIMENTAL
Intervention: I-BiT DVD footage
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: I-BiT modified shooter game (Nux)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Non-I-BiT games (non-interactive binocular treatment)
Number of subjects: 75
Study: 24732630

Group type: EXPERIMENTAL
Intervention: Fecal occult blood test (FOBT)
Number of subjects: 3195

Group type: EXPERIMENTAL
Intervention: Colonoscopy
Number of subjects: 3195
Study: 22639845

Group type: EXPERIMENTAL
Intervention: CAF+CTG
Number of subjects: 29

Group type: COMPARATOR
Intervention: CAF alone
Number of subjects: 29
Study: 20737524

Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg) plus fluoxetine (20 mg/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Fluoxetine (20 mg/day) plus placebo
Number of subjects: 42